Argus Forecasts Strong Price Appreciation for Merck & Co., Inc. (NYSE:MRK) Stock

Merck Just Gained 19% in a Month. What Would It Take to Get MRK Stock Up to $200?

The post Merck Just Gained 19% in a Month. What Would It Take to Get MRK Stock Up to $200? appeared first on 24/7 Wall St.. The setup around Merck (NYSE:MRK) shares heading into September is unusual for a mega-cap pharma. Wall Street’s consensus target sits below the current stock price, meaning analysts would have to raise their numbers for $200 to come into view. There’s a lot to consider in the near future: a dense stretch of FDA decision dea…

Argus Forecasts Strong Price Appreciation for Merck & Co., Inc. (NYSE:MRK) Stock

Argus increased their target price on Merck & Co., Inc. from $145.00 to $170.00 and gave the company a "buy" rating in a report on Tuesday.